WO2021107823A9 - Highly specific antibodies to prame protein and use of said antibodies - Google Patents
Highly specific antibodies to prame protein and use of said antibodies Download PDFInfo
- Publication number
- WO2021107823A9 WO2021107823A9 PCT/RU2020/050352 RU2020050352W WO2021107823A9 WO 2021107823 A9 WO2021107823 A9 WO 2021107823A9 RU 2020050352 W RU2020050352 W RU 2020050352W WO 2021107823 A9 WO2021107823 A9 WO 2021107823A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibodies
- highly specific
- prame protein
- specific antibodies
- prame
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019138407A RU2774194C2 (en) | 2019-11-27 | Antibodies directed at epitopes located in area of 160-200 amino acid bases of human prame protein, and their application | |
| RU2019138407 | 2019-11-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2021107823A2 WO2021107823A2 (en) | 2021-06-03 |
| WO2021107823A9 true WO2021107823A9 (en) | 2021-07-29 |
Family
ID=76033604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2020/050352 WO2021107823A2 (en) | 2019-11-27 | 2020-11-26 | Highly specific antibodies to prame protein and use of said antibodies |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2021107823A2 (en) |
-
2020
- 2020-11-26 WO PCT/RU2020/050352 patent/WO2021107823A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021107823A2 (en) | 2021-06-03 |
| RU2019138407A3 (en) | 2021-05-27 |
| RU2019138407A (en) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3768314A4 (en) | Antibodies against signal-regulatory protein alpha and methods of use | |
| EP3515490B8 (en) | Antibodies against signal-regulatory protein alpha and methods of use | |
| EP3852805A4 (en) | Anti-lilrb2 antibodies and methods of use thereof | |
| EP4031177A4 (en) | Anti-tnfr2 antibodies and methods of use | |
| EP3985025A4 (en) | Antibody to tigit and use thereof | |
| EP3966248A4 (en) | Humanized antibodies to mucin-16 and methods of use thereof | |
| EP3746123A4 (en) | Antibodies to galectin-3 and methods of use thereof | |
| EP3930756A4 (en) | Lilrb4-binding antibody and methods of use thereof | |
| IL290741A (en) | Anti-cd96 antibodies and methods of use thereof | |
| IL287282A (en) | Anti-mertk antibodies and their methods of use | |
| SG11202108734VA (en) | Anti-trem2 antibodies and methods of use thereof | |
| EP3946354A4 (en) | Heteromultimeric proteins and methods of use thereof | |
| IL289952A (en) | Anti-ms4a4a antibodies and methods of use thereof | |
| EP3740509A4 (en) | Anti-pd-l1 antibodies and methods of use | |
| EP3826641A4 (en) | Compositions of fcrn antibodies and methods of use thereof | |
| EP3768723A4 (en) | Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor | |
| IL285401A (en) | Anti-clec2d antibodies and methods of use thereof | |
| IL290509A (en) | Antibodies that bind to lrp5 proteins and methods of use | |
| EP3411070A4 (en) | Egfl6 specific monoclonal antibodies and methods of their use | |
| IL291461A (en) | Anti-alpha-synuclein antibodies and methods of use thereof | |
| EP3867272A4 (en) | Use of anti-fam19a5 antibodies | |
| EP3746484A4 (en) | Anti-ms4a6a antibodies and methods of use thereof | |
| EP3753955A4 (en) | Cd38 protein antibody and application thereof | |
| IL283136A (en) | Antibodies to mucin-16 and methods of use thereof | |
| EP3634459A4 (en) | Antibodies to tip1 and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20892046 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 20892046 Country of ref document: EP Kind code of ref document: A2 |